Male and female rats show different behavioral patterns during cannabinoid withdrawal
Male and female rats exhibited qualitatively different withdrawal behaviors from the synthetic cannabinoid WIN 55,212-2, with females showing precipitated withdrawal at lower antagonist doses and sex-specific anxiety-like behaviors emerging weeks later.
Quick Facts
What This Study Found
Females showed precipitated withdrawal at 3 mg/kg rimonabant while males required 10 mg/kg. The individual somatic behaviors contributing to withdrawal scores differed by sex. At two weeks abstinence, females showed more grooming and marble manipulation than males, suggesting sex-specific anxiety-like responses.
Key Numbers
Females: precipitated withdrawal at 3 mg/kg rimonabant. Males: precipitated withdrawal at 10 mg/kg. Spontaneous withdrawal quantifiable up to 24 hours post-final infusion. Estrous cycle was not affected by WIN infusions and did not correlate with withdrawal scores.
How They Did This
Adult male and female Long-Evans rats received escalating doses of WIN 55,212-2 via intrajugular infusion. Precipitated withdrawal was induced with rimonabant. Somatic behaviors were scored, locomotor activity tracked, and anxiety-like behavior assessed with elevated plus maze, open field, and marble burying tests at one and two weeks abstinence.
Why This Research Matters
Most cannabinoid withdrawal research has focused on males. This study demonstrates that withdrawal is not just more or less severe between sexes but qualitatively different, which has implications for how withdrawal is assessed and treated in clinical settings.
The Bigger Picture
Clinical data show that women often report more severe cannabis withdrawal than men. This animal study supports those findings and adds that the types of withdrawal behaviors differ, not just the intensity, reinforcing the need for sex-specific approaches to treating cannabis dependence.
What This Study Doesn't Tell Us
Used a synthetic cannabinoid (WIN 55,212-2), not THC, so results may not directly map to cannabis withdrawal. Rat behavior does not perfectly model human withdrawal experience. The anxiety-like tests at one and two weeks showed limited drug-treatment effects.
Questions This Raises
- ?Would THC withdrawal produce the same sex-dependent patterns?
- ?What biological mechanisms make females more sensitive to cannabinoid withdrawal?
- ?Could sex-specific withdrawal profiles inform tailored treatment approaches?
Trust & Context
- Key Stat:
- Females showed withdrawal at 3 mg/kg rimonabant vs. 10 mg/kg for males
- Evidence Grade:
- Well-designed animal study with multiple behavioral measures and both sexes represented. Limited by use of synthetic cannabinoid rather than THC and by inherent constraints of translating rat behavior to human experience.
- Study Age:
- Published in 2024 with controlled laboratory experiments.
- Original Title:
- Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2.
- Published In:
- Pharmacology, biochemistry, and behavior, 236, 173707 (2024)
- Database ID:
- RTHC-05159
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Do men and women experience cannabis withdrawal differently?
Clinical data suggest women often report more severe withdrawal. This animal study found that female rats also showed withdrawal at lower doses and exhibited different specific behaviors than males, supporting the idea of sex-based differences in withdrawal.
What is precipitated withdrawal?
Precipitated withdrawal occurs when an antagonist drug (in this case rimonabant) rapidly blocks cannabinoid receptors, triggering immediate withdrawal symptoms rather than waiting for the drug to naturally clear the body.
Read More on RethinkTHC
- 30-days-without-weed
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- anger-irritability-quitting-weed-withdrawal
- appetite-after-quitting-weed
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- caffeine-weed-withdrawal
- cannabinoid-hyperemesis-syndrome
- cannabis-withdrawal-complete-guide
- cannabis-withdrawal-severity-levels-mild-moderate-severe
- cannabis-withdrawal-syndrome
- cannabis-withdrawal-syndrome-dsm-5
- cannabis-withdrawal-syndrome-timeline-day-by-day
- cannabis-withdrawal-vs-alcohol-nicotine-opioid-comparison
- creativity-without-weed-quitting-artist-musician
- emotional-after-quitting-weed-crying
- first-week-quitting-weed
- hobbies-after-quitting-weed
- how-long-does-weed-withdrawal-last
- how-long-to-feel-normal-after-quitting-weed
- identity-after-quitting-weed
- leaving-stoner-culture-identity
- marijuana-withdrawal-symptoms
- money-saved-quitting-weed-calculator
- night-sweats-quitting-weed-withdrawal
- one-year-sober-weed
- paws-cannabis-post-acute-withdrawal
- quitting-weed-creativity
- quitting-weed-face-changes-skin
- quitting-weed-weight-loss-gain
- weed-cravings
- weed-depersonalization-derealization
- weed-paws-withdrawal
- weed-withdrawal-anger
- weed-withdrawal-brain-fog
- weed-withdrawal-chest-tightness-heart-palpitations
- weed-withdrawal-crying-emotional
- weed-withdrawal-depression
- weed-withdrawal-headaches
- weed-withdrawal-irritability
- weed-withdrawal-men
- weed-withdrawal-mood-swings
- weed-withdrawal-nausea
- weed-withdrawal-night-sweats
- weed-withdrawal-no-appetite
- weed-withdrawal-sweating-detox
- weed-withdrawal-timeline
- weed-withdrawal-vs-alcohol
- weed-withdrawal-women
- what-happens-when-you-stop-smoking-weed
Cite This Study
https://rethinkthc.com/research/RTHC-05159APA
Brewer, Abigail L; Felter, Claire E; Sternitzky, Anna R; Spencer, Sade M. (2024). Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2.. Pharmacology, biochemistry, and behavior, 236, 173707. https://doi.org/10.1016/j.pbb.2024.173707
MLA
Brewer, Abigail L, et al. "Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2.." Pharmacology, 2024. https://doi.org/10.1016/j.pbb.2024.173707
RethinkTHC
RethinkTHC Research Database. "Somatic and anxiety-like behaviors in male and female rats d..." RTHC-05159. Retrieved from https://rethinkthc.com/research/brewer-2024-somatic-and-anxietylike-behaviors
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.